PortfoliosLab logoPortfoliosLab logo
WDNA vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WDNA vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WDNA achieves a 13.32% return, which is significantly higher than XLVI's 2.50% return.


WDNA

1D
0.49%
1M
8.93%
YTD
13.32%
6M
11.11%
1Y
50.90%
3Y*
5.47%
5Y*
-5.03%
10Y*

XLVI

1D
1.53%
1M
2.15%
YTD
2.50%
6M
2.57%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WDNA vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between WDNA and XLVI is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 30, 2025

0.56

WDNA vs. XLVI - Sectors Allocation Comparison


Sectors
WDNA
XLVI

Healthcare

85.0%
100.0%

Basic Materials

6.5%

-

Consumer Defensive

3.0%

-

Energy

1.1%

-

Communication Services

-

-

Consumer Cyclical

-

-

Financial Services

-

100.2%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

WDNA
85.0%
XLVI
100.0%

Basic Materials

WDNA
6.5%
XLVI

-

Consumer Defensive

WDNA
3.0%
XLVI

-

Energy

WDNA
1.1%
XLVI

-

Communication Services

WDNA

-

XLVI

-

Consumer Cyclical

WDNA

-

XLVI

-

Financial Services

WDNA

-

XLVI
100.2%

Industrials

WDNA

-

XLVI

-

Real Estate

WDNA

-

XLVI

-

Technology

WDNA

-

XLVI

-

Utilities

WDNA

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WDNA vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDNA
WDNA Risk / Return Rank: 6666
Overall Rank
WDNA Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
WDNA Sortino Ratio Rank: 6666
Sortino Ratio Rank
WDNA Omega Ratio Rank: 5656
Omega Ratio Rank
WDNA Calmar Ratio Rank: 8585
Calmar Ratio Rank
WDNA Martin Ratio Rank: 5959
Martin Ratio Rank

XLVI

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDNA vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


WDNAXLVIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.32

Calmar ratioReturn relative to maximum drawdown

4.37

Martin ratioReturn relative to average drawdown

9.80

WDNA vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Drawdowns

WDNA vs. XLVI - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for WDNA and XLVI.


Loading charts...

Drawdown Indicators


WDNAXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-58.87%

-8.14%

-50.73%

Max Drawdown (1Y)

Largest decline over 1 year

-11.70%

Max Drawdown (3Y)

Largest decline over 3 years

-38.25%

Max Drawdown (5Y)

Largest decline over 5 years

-58.87%

Current Drawdown

Current decline from peak

-27.05%

-0.97%

-26.08%

Average Drawdown

Average peak-to-trough decline

-35.56%

-1.94%

-33.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.21%

Volatility

WDNA vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


WDNAXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.39%

Volatility (6M)

Calculated over the trailing 6-month period

16.98%

Volatility (1Y)

Calculated over the trailing 1-year period

25.90%

11.06%

+14.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.14%

11.06%

+14.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.06%

11.06%

+14.00%

WDNA vs. XLVI - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is higher than XLVI's 0.35% expense ratio.


Dividends

WDNA vs. XLVI - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 4.03%, less than XLVI's 11.17% yield.


PositionTTM20252024202320222021
WDNA
WisdomTree BioRevolution Fund
4.03%4.57%0.75%0.80%0.38%0.10%
XLVI
State Street Health Care Select Sector SPDR Premium Income ETF
11.17%5.73%0.00%0.00%0.00%0.00%

Frequently Asked Questions


WDNA and XLVI have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLVI is cheaper with a 0.35% expense ratio, compared with 0.45% for WDNA.

XLVI has the higher dividend yield at 11.17%, compared with 4.03% for WDNA.

WDNA is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: WisdomTree and State Street. Their fees differ too: 0.45% for WDNA and 0.35% for XLVI.

Portfolio Optimizer

Find the right allocation for WDNA and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer